O36.0131 Maternal care for anti-D [Rh] antibodies, third trimester, fetus 1

Name of the Condition

• Maternal care for anti-D [Rh] antibodies, third trimester, fetus 1
• ICD Code: O36.0131

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has anti-D (Rh) antibodies and is carrying a single fetus. The focus is on managing the risk of hemolytic disease of the fetus and newborn (HDFN), which can occur if the fetus is Rh-positive. Care includes assessment of antibody levels, fetal monitoring, and planning for potential interventions to prevent or treat complications.

Causes

The presence of anti-D antibodies typically results from prior exposure to Rh-positive blood, such as during a previous pregnancy with an Rh-positive fetus, blood transfusion, or trauma. These antibodies can cross the placenta and attack the red blood cells of an Rh-positive fetus, leading to hemolysis.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Trauma or procedures (e.g., amniocentesis) during pregnancy that may cause fetal-maternal bleeding
• Unknown prior sensitization (e.g., from unrecognized fetal-maternal hemorrhage)

Symptoms

• No direct maternal symptoms; the condition is identified through laboratory testing
• Potential fetal complications (e.g., anemia, hydrops fetalis) may develop, but these are not maternal symptoms

Diagnosis

Diagnosis involves testing the mother's blood for anti-D antibodies, assessing antibody levels, and using Doppler ultrasound or other fetal monitoring techniques to evaluate for signs of hemolytic disease. Fetal blood typing may be performed if needed.

Treatment Options

Treatment may include close monitoring of antibody titers, fetal surveillance (e.g., ultrasound, non-stress tests), and planning for delivery timing. In severe cases, intrauterine transfusions or early delivery may be considered to manage fetal anemia.

Prognosis and Follow-Up

With appropriate monitoring and intervention, outcomes for the fetus can be favorable. Follow-up care focuses on continued fetal assessment and preparation for delivery, including coordination with neonatology for postnatal care if HDFN is suspected.

Complications

Potential complications include fetal anemia, hydrops fetalis, and kernicterus. Maternal complications are rare but may include increased risk of preeclampsia or other pregnancy-related issues.

Lifestyle & Prevention

Prevention of sensitization in Rh-negative women includes administration of Rh immunoglobulin (RhoGAM) after sensitizing events. Avoiding unnecessary blood exposure and ensuring proper prenatal care can reduce risk.

When to Seek Professional Help

Seek medical attention if there are signs of fetal distress (e.g., decreased movement) or if antibody levels rise significantly. Prompt evaluation is critical for managing potential complications.

Tips for Medical Coders

Document the trimester (third) and fetus count (1) clearly. Ensure the presence of anti-D antibodies and the need for maternal care are supported by clinical notes. Code O36.0131 is specific to the third trimester and a single fetus; verify documentation aligns with these details.